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demographic characteristics, total health care utilization and cost burden were
higher for patients who suffered a TIA after an NVAF diagnosis, relative to patients
who did not.
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OBJECTIVES: To compare clinical outcomes and cost burden of patients who suf-
fered a stroke during the 180 days after diagnosis of non-valvular atrial fibrillation
(NVAF) with patients who did not. METHODS: Based on 2005-2007 US Medical
insurance claim files, patients aged 65 years and older who have had two or more
primary diagnoses of NVAF, occurring within 30 days of one another, were selected.
The 180-day follow-up mortality rate, health care facility use and costs for patients
with and without incidences of stroke were compared. Risk adjustment was per-
formed using the propensity score matching (PSM) method with the ProbChoice™
algorithm. RESULTS: Out of patients who were identified with and without NVAF
pre-stroke (n18,195), 541 (2.97%) suffered a stroke during the 180 days after the
NVAF diagnosis. After PSM risk-adjustment for pre-specified covariates, mortality
(7.39% vs. 1.07% p0.0001), outpatient emergency room (ER) visits (80.59% vs.
48.11% p0.0001), readmission rates (1.85% vs. 0.40%, p0.0001), transient isch-
emic attacks (44 vs. 8 /100 person years), and intracranial hemorrhage rates (71 vs.
7/100 person years) were all higher for patients who suffered a stroke compared to
those who did not. Although risk-adjusted outpatient ER costs and office visit costs
did not differ significantly between the two groups, patients who suffered a stroke
had significantly higher inpatient ($24,231 vs. $15,137, p0.0001) and total ($33,439
vs. $13,782, p0.0001) expenditures. CONCLUSIONS: Most of the adverse events
analyzed were higher for patients who suffered a stroke after an NVAF diagnosis
relative to patients who did not. Total health care utilizations and health care costs
were also significantly increased.
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OBJECTIVES: To ascertain the direct costs related to hospitalization in the Physical
Medicine Service and Rehabilitation of a tertiary referral hospital during the year
2009. METHODS: An epidemiological, observational retrospective study was car-
ried out in the Central University Hospital of Asturias –HUCA-, Spain. All patients
admitted to the Rehabilitation Unit (RU) and suffering from a cerebrovascular dis-
ease (CVD), brain injury (BI), spinal cord injury (SCI) or amputations were included.
RU services was acting as secondary referral level -SRL- in case of BI and CVD. In
contrast, SCI and amputations were attended in the same RU as tertiary referral
level-TRL-. A cost-analysis following hospital perspective was performed recording
all health resources at patient level. Next, direct costs were calculated attaching a
published cost to each resource. Socio-demographic and clinical variables were
registered to describe the sample and to facilitate external comparisons. Mean
costs per patient were calculated considering each of the pathologies and compar-
ing SRL and TRL. Costs were defined in 2009 Euros. Chi2 test was used to compare
socio-demographic and clinical variables between groups. Next, parametric (Stu-
dent’s t test and ANCOVA analysis) and non parametric analysis (bootstrapping)
were applied to estimate economic differences between groups. RESULTS: A total
of 243 patients admitted to RU were assessed. Mean age (SD) was 59.62 years (1.41)
and 71.2% males. Mean cost per patient (SD): BI(n 15) 28,837.87(23,998.80); CVD(n
116), 31,751.05(19,151.26); SCI(n 105), 27,635.39(24,856.55); amputations(n 7),
24,342.86(5,426.48). Mean SRL cost was significantly higher than TRL:
31,417.48(19,681.03) and 27,429.61(24,106.37), respectively (p 0.013). Total anual
SRL cost was 4,115,751.43 and 3,072,167.39 TRL. CONCLUSIONS: Forty-six percent
of total activity in the RU is related to TRL requiring 43% of total expenditure.
Further research comparing this policy with early discharge and home rehabilita-
tion should be implemented to promote the efficiency of this service.
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OBJECTIVES: Atrial fibrillation (AF) is a prevalent disease that often requires costly
hospital care, but the cost of hospital utilization has not been reported in Canada.
The purpose of this study was to estimate the cost of hospital utilization for AF in
Canada. METHODS: Three national administrative databases (Discharge Abstract
Database, Same Day Surgery and National Ambulatory Care Reporting System) for
the year 2007/08 were used to capture admissions, same day surgeries and emer-
gency department (ED) visits. Provincial/territorial data were extrapolated to the
national level using age-gender census information where necessary. Records with
a most responsible diagnosis (MRD) of AF, atrial flutter or a secondary diagnosis of
AF were included in the analysis. Hospital costs were estimated by applying an
average cost per weighted case to the resource intensity weight that was provided
for each admission/visit, and then adding the physician fees for admissions, sur-
geries and interventions. All cost estimates are expressed in 2010 Canadian dollars.
RESULTS: In 2007/08, the number of hospital admissions with MRD of AF was
10,924 for men and 11,899 for women, same day surgeries was 3,910 for men and
1,797 for women and ED visits were 29,754 for men and 28,312 for women. The
average cost per admission was $6,718 with an average length of stay of 5.7 days.
The average cost of same day surgery was $3,524 and an ED visit was $849. The total
hospital cost for patients with AF was $815M; $710M for hospital admissions,
$72.9M for ED visits, and $31.8M for same day surgery. Most of the costs were for
hospital admissions when AF was listed as a comorbidity ($558.2M, 69%)
CONCLUSIONS: The substantial cost burden of AF in the acute care sector is driven
by the consequences of AF, while the costs for specific treatments for AF are rela-
tively low.
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OBJECTIVES: Acute coronary syndrome (ACS) is the most important clinical con-
sequence of coronary artery disease and a leading cause of death worldwide. This
study aims to assess the costs of ACS from a social and health insurance perspec-
tive evaluating direct costs, production losses and intangible costs in terms of
quality adjusted life years (QALYs) lost. METHODS: A bottom-up incidence ap-
proach was used. ACS-Patients with one or more ACS events were extracted from
a national hospital database and from mortality statistics. Remaining life years of
surviving patients were modelled on age, gender and life expectancy statistics.
Inpatient costs include acute care and rehabilitation in 2008. Outpatient costs in-
clude costs for ambulance, visits to GP and cardiologist, outpatient diagnostics,
medication and rehabilitation. Production losses were calculated according to the
human capital approach, including absenteeism, permanent disability and prema-
ture death. Intangible costs were calculated based on literature data. Cost data are
derived from official price lists, literature and experts. Validation of clinical data
was conducted using the AMIS-PLUS registry. RESULTS: A total of 14,955 patients
experienced a total of 16,815 ACS events in 2008; 2,752 died as a consequence of
these. This resulted in 19,064 hospital stays with an average length of stay in acute
care of 8.9 days per patient. Total direct costs amounted to 690 Mio Swiss Francs
(CHF) for the society and 523 Mio CHF for health insurers. Forty-four percent belong
to inpatient and 56% to outpatient services. Production losses were 515 Mio. CHF
and intangible costs resulted in 37,457 QALYs lost. Average total direct costs and
production losses per patient were 80,873 CHF. Results appear robust in sensitivity
analysis. CONCLUSIONS: ACS causes considerable costs in terms of direct medical
expenditures, lost production and premature death, even without taking into ac-
count costs for its chronic consequences such as congestive heart failure.
PCV52
TEMPORAL TRENDS IN THE HOSPITAL BURDEN OF ATRIAL FIBRILLATION AND
STROKE ON SECONDARY CARE COSTS IN ENGLAND BETWEEN 2006 AND 2009
Bakhai A1, Righetti C2, Punekar Y2, Majeed A3
1AMORE Health Ltd, London, UK, 2Sanofi-aventis, Surrey, UK, 3Imperial College, London, UK
OBJECTIVES: Atrial fibrillation (AF) is the commonest cardiac arrhythmia found in
clinical practice with an increasing prevalence in the aging population. Local esti-
mates vary from 1.2 to 2.5%. The objective of our study was to evaluate the burden
of AF on secondary care costs in England, which is responsible for substantial
cardiovascular morbidity and mortality. METHODS: AF and stroke event and cost
data captured in Hospital Episode Statistics(HES), between 2006 and 2009, was
analysed to estimate the trends in hospital episodes in England. RESULTS: A total
of 193,742 patients with a primary or secondary diagnosis of AF were hospitalised
in 2009, representing a 19% increase in AF patients on the previous 3 years. During
this period there were 239,746 hospital spells with a diagnosis of AF; a 22% increase
from 2006-2009. The total inpatient cost attributable to AF increased from £353
million in 2006 to a total of £361 million in 2009. As a proportion of all admissions,
AF admissions were 1.1% in 2006 to 1.2% in 2009 and represented 1,162,213 bed days
occupied in 2006 versus 1,108,283 in 2009. In 2009, of the 193,742 patients with a
diagnosis of AF, 5,391 subsequently had a stroke. This gives a conversion rate from
AF to stroke of 3.1% of patients – up from 2.5% in 2006. During this same period, the
average length of stay for the stroke patient with AF has increased from 38 days to
43 days (higher than those patients who have only had a stroke). CONCLUSIONS:
Despite advances in both AF and stroke management, AF presents a significant and
increasing burden on hospital care in England. New initiatives are needed to detect
AF early and prevent hospital admissions or to manage AF in rapid access arrhyth-
mia clinics where appropriate therapies to manage the rate, rhythm and cardio-
vascular risks can be dispensed without needing admission.
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OBJECTIVES: The objective of this study was to quantify, for the first time in a
Spanish population, the time and cost burden of informal care for pts with heart
failure. METHODS: A descriptive analysis of a multicenter, prospective observa-
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